More than two dozen congressional Democrats have signed on to a new bill aimed at injecting transparency into funding for ...

The biosimilars market is estimated to reach USD 66.9 billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Amgen is set to release its second-quarter earnings next month, and analysts are projecting modest single-digit growth in ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

CWM LLC raised its stake in Amgen by 8% in Q1, buying 11,175 more shares worth nearly $47 million. Other institutional ...

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...

Shares of The Trade Desk received a nice bump in after-hours trading on July 14 after it was announced that the ad-tech company would be joining the S&P 500 beginning on July 18. The Trade Desk, which ...

There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape ...

It’s called the Amgen Biotech Experience and for a number of teachers across the Piedmont, it could be the key to helping ...